Literature DB >> 1543939

Intravenous drug use and HIV transmission amongst inmates in Scottish prisons.

K G Power1, I Markova, A Rowlands, K J McKee, P J Anslow, C Kilfedder.   

Abstract

The intravenous drug use behaviour and HIV risk reduction strategies used by a group of Scottish inmates prior to prison, during imprisonment and as expected after release was investigated. From a sample of 559 inmates (480 males and 79 females) 27.5% were involved in IVDU prior to imprisonment, 7.7% on at least one occasion during a period of imprisonment and 14.7% expected to do so after release. Prior to imprisonment 17.3% had shared needles, 5.7% at some time during imprisonment and 4.3% expected to do so after release. Some form of HIV risk reduction strategies were practised by the majority of IVDU inmates prior to imprisonment, during imprisonment and were expected to continue after release. The most at risk inmates were those who continued to share injecting equipment without reduction and without sterilizing. The reduction in IVDU and needle sharing during imprisonment in comparison to prior to imprisonment was paralleled by a self-perceived reduction of personal risk from HIV during imprisonment.

Mesh:

Year:  1992        PMID: 1543939     DOI: 10.1111/j.1360-0443.1992.tb01898.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  9 in total

1.  Management of prisoners with HIV infection. Prevention would be better than care.

Authors:  A J Ashworth
Journal:  BMJ       Date:  2001-07-28

2.  HIV infection in prisons. Most drug injectors stop injecting on entry to prison.

Authors:  D Shewan; M Reid; A Macpherson; J B Davies
Journal:  BMJ       Date:  1995-05-13

3.  Outbreak of HIV infection in a Scottish prison.

Authors:  A Taylor; D Goldberg; J Emslie; J Wrench; L Gruer; S Cameron; J Black; B Davis; J McGregor; E Follett
Journal:  BMJ       Date:  1995-02-04

4.  The changing picture of substance abuse problems among Finnish prisoners.

Authors:  Tomi Lintonen; Yaira Obstbaum; Jorma Aarnio; Virpi von Gruenewaldt; Sirpa Hakamäki; Juha Kääriäinen; Aino Mattila; Heikki Vartiainen; Päivi Viitanen; Terhi Wuolijoki; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-05-06       Impact factor: 4.328

5.  Incidence and risk for acute hepatitis C infection during imprisonment in Australia.

Authors:  Kate Dolan; Suzy Teutsch; Nicolas Scheuer; Michael Levy; William Rawlinson; John Kaldor; Andrew Lloyd; Paul Haber
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

6.  HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention.

Authors:  Prithwish De; Nancy Connor; Françoise Bouchard; Donald Sutherland
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

7.  The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico.

Authors:  Robin A Pollini; Jorge Alvelais; Manuel Gallardo; Alicia Vera; Remedios Lozada; Carlos Magis-Rodriquez; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2009-04-21       Impact factor: 4.492

8.  Childhood ADHD symptoms are associated with lifetime and current illicit substance-use disorders and in-site health risk behaviors in a representative sample of Latino prison inmates.

Authors:  Rafael A González; María C Vélez-Pastrana; José J Ruiz Varcárcel; Frances R Levin; Carmen E Albizu-García
Journal:  J Atten Disord       Date:  2012-12-04       Impact factor: 3.256

9.  Pattern of Substance Abuse and Prevalence of Risk Factors of HIV and Hepatitis among Addicted Women in Western Iran.

Authors:  Behrooz Hamzeh; Zeinab Moradi; Farid Najafi; Mehdi Moradinazar
Journal:  Int J Prev Med       Date:  2019-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.